United States · Venture startup

Who invested in Nomi Health

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
VentureAug 2025
Investors
2
See who backed them

The rounds

  1. Aug 2025
    VentureAmount undisclosed

    Source recorded

Founders and team

From Nomi Health's own website: 3 founders, 2 on the team.

Mark NewmanCo-founder and Chief Executive Officer
Boe HartmanCo-Founder & Chief Technology Officer
Joshua WalkerCo-founder and Chief Operating Officer
  • Betsy McVayPresident of Analytics, Nomi Health
  • Jeff PashalidesChief Financial Officer

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Nomi Health as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

KickstartVC firmPer its own site
Kickstart Seed FundVC firmPer its own site
Starttech VenturesAcceleratorPer its own site
Arbor VenturesVC firmPer its own site

Quick answers about Nomi Health

Who invested in Nomi Health?

Nomi Health's investors include Pelion Venture Partners and Peterson Ventures.

How much has Nomi Health raised?

Nomi Health has raised 1 round since 2025, none with a disclosed amount.

When did Nomi Health last raise?

Nomi Health's most recent round was a Venture in Aug 2025.

Who backed Nomi Health first?

Nomi Health's first round on record, in Aug 2025, was backed by Pelion Venture Partners and Peterson Ventures.

What stage is Nomi Health at?

Nomi Health's latest named round is a Venture, in Aug 2025.

Where is Nomi Health based?

Nomi Health is based in the United States.

Companies like Nomi Health

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.